Huneif, M.A.; Mahnashi, M.H.; Jan, M.S.; Shah, M.; Almedhesh, S.A.; Alqahtani, S.M.; Alzahrani, M.J.; Ayaz, M.; Ullah, F.; Rashid, U.;
et al. New Succinimide–Thiazolidinedione Hybrids as Multitarget Antidiabetic Agents: Design, Synthesis, Bioevaluation, and Molecular Modelling Studies. Molecules 2023, 28, 1207.
https://doi.org/10.3390/molecules28031207
AMA Style
Huneif MA, Mahnashi MH, Jan MS, Shah M, Almedhesh SA, Alqahtani SM, Alzahrani MJ, Ayaz M, Ullah F, Rashid U,
et al. New Succinimide–Thiazolidinedione Hybrids as Multitarget Antidiabetic Agents: Design, Synthesis, Bioevaluation, and Molecular Modelling Studies. Molecules. 2023; 28(3):1207.
https://doi.org/10.3390/molecules28031207
Chicago/Turabian Style
Huneif, Mohammed A., Mater H. Mahnashi, Muhammad Saeed Jan, Muhammad Shah, Sultan A. Almedhesh, Seham M. Alqahtani, Mohammad Jamaan Alzahrani, Muhammad Ayaz, Farhat Ullah, Umer Rashid,
and et al. 2023. "New Succinimide–Thiazolidinedione Hybrids as Multitarget Antidiabetic Agents: Design, Synthesis, Bioevaluation, and Molecular Modelling Studies" Molecules 28, no. 3: 1207.
https://doi.org/10.3390/molecules28031207
APA Style
Huneif, M. A., Mahnashi, M. H., Jan, M. S., Shah, M., Almedhesh, S. A., Alqahtani, S. M., Alzahrani, M. J., Ayaz, M., Ullah, F., Rashid, U., & Sadiq, A.
(2023). New Succinimide–Thiazolidinedione Hybrids as Multitarget Antidiabetic Agents: Design, Synthesis, Bioevaluation, and Molecular Modelling Studies. Molecules, 28(3), 1207.
https://doi.org/10.3390/molecules28031207